デフォルト表紙
市場調査レポート
商品コード
1060770

世界の遺伝子編集市場:規模・現状・予測 (2022年~2028年)

Global Gene Editing Market Size, Status and Forecast 2022-2028

出版日: | 発行: QYResearch | ページ情報: 英文 92 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.55円
世界の遺伝子編集市場:規模・現状・予測 (2022年~2028年)
出版日: 2022年03月01日
発行: QYResearch
ページ情報: 英文 92 Pages
納期: 2~3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、遺伝子編集 (Gene Editing) 市場について調査しており、市場規模や動向の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析:タイプ別
    • 世界の遺伝子編集の市場規模成長率:タイプ別 (2022-2028)
    • Zinc finger nucleases (ZFNs)
    • Transcription Activator-Like Effector-based Nucleases (TALENs)
    • CRISPR-Cas system
  • 市場:アプリケーション別
    • 世界の遺伝子編集の市場シェア:アプリケーション別 (2022-2028)
    • Biotechnology & Pharmaceutical Companies
    • Academic & Government Research Institutes
    • Contract Research Organizations
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界の遺伝子編集 市場規模
  • 遺伝子編集の市場規模:地域別
    • 遺伝子編集 成長率:地域別 (2022-2028)
    • 遺伝子編集 市場シェア:地域別 (2022-2028)
  • 業界動向
    • トレンド
    • ユースケース

第3章 主要企業

  • 遺伝子編集の収益:企業別 (2022 & 2028)
  • 遺伝子編集の主要企業の本社および事業エリア
  • 主要企業 遺伝子編集の製品/ソリューション/サービス
  • 市場参入時期: 遺伝子編集 市場
  • M&A, 拡張計画

第4章 内訳:タイプ/アプリケーション別

  • 世界の遺伝子編集 市場規模:タイプ別 (2022-2028)
  • 世界の遺伝子編集 市場規模:アプリケーション別 (2022-2028)

第5章 北米

  • 北米の遺伝子編集 市場予測 (2022-2028)
  • 遺伝子編集 主要企業: 北米
  • 北米の遺伝子編集 市場規模:タイプ別
  • 北米の遺伝子編集 市場規模:アプリケーション別

第6章 欧州

  • 欧州の遺伝子編集 市場予測 (2022-2028)
  • 遺伝子編集 主要企業: 欧州
  • 欧州の遺伝子編集 市場規模:タイプ別
  • 欧州の遺伝子編集 市場規模:アプリケーション別

第7章 アジア太平洋地域

  • アジア太平洋地域 遺伝子編集 市場予測 (2022-2028)
  • 遺伝子編集 主要企業: アジア太平洋地域
  • アジア太平洋地域 遺伝子編集 市場規模:タイプ別
  • アジア太平洋地域 遺伝子編集 市場規模:アプリケーション別

第8章 その他の国

  • ラテンアメリカ
    • ラテンアメリカの遺伝子編集 市場分析
    • 主要企業: ラテンアメリカ
  • 中東・アフリカ
    • 中東・アフリカの遺伝子編集 市場分析
    • 主要企業: 中東・アフリカ

第9章 主要企業のプロファイル

  • Thermo Fisher Scientific
  • Merck
  • Horizo​​n Discovery
  • Sangamo BioSciences
  • Integrated DNA Technologies
  • Lonza
  • New England Biolabs
  • OriGene Technologies
  • Transposagen Biopharmaceuticals
  • Editas Medicine
  • CRISPR Therapeutics
  • RGen Solutions
  • Sigma-Aldrich
  • GeneCopoeia
  • Genscript Biotech

第10章 市場動向

  • 業界動向
  • 市場の促進要因
  • 市場の課題
  • 市場の抑制要因

第11章 主な調査結果

第12章 付録

図表

LIST OF TABLES

List of Tables

  • Table 1. Global Gene Editing Market Size Growth Rate by Type (2022-2028) (US$ Million)
  • Table 2. Key Players of Zinc finger nucleases (ZFNs)
  • Table 3. Key Players of Transcription Activator-Like Effector-based Nucleases (TALENs)
  • Table 4. Key Players of CRISPR-Cas system
  • Table 5. Global Gene Editing Market Size Growth by Application (2022-2028) (US$ Million)
  • Table 6. Global Gene Editing Market Size by Regions (2022-2028) (US$ Million)
  • Table 7. Global Gene Editing Market Share by Regions (2022-2028)
  • Table 8. Market Top Trends
  • Table 9. Market Use Cases
  • Table 10. Global Gene Editing Revenue by Players (2022 & 2028) (US$ Million)
  • Table 11. Global Gene Editing Market Share by Players (2022 &2028)
  • Table 12. Key Players Headquarters and Area Served
  • Table 13. Key Players Gene Editing Product/Solution/Service
  • Table 14. Date of Enter into Gene Editing Market
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Gene Editing Market Size by Type (2022-2028) (US$ Million)
  • Table 17. Global Gene Editing Market Size Share by Type (2022-2028)
  • Table 18. Global Gene Editing Market Size by Application (2022-2028) (US$ Million)
  • Table 19. Global Gene Editing Market Size Share by Application (2022-2028)
  • Table 20. North America Key Players Gene Editing Revenue (2022 & 2028) & (US$ Million)
  • Table 21. North America Key Players Gene Editing Market Share (2022 & 2028)
  • Table 22. North America Gene Editing Market Size by Type (2022-2028) (US$ Million)
  • Table 23. North America Gene Editing Market Share by Type (2022-2028)
  • Table 24. North America Gene Editing Market Size by Application (2022-2028) (US$ Million)
  • Table 25. North America Gene Editing Market Share by Application (2022-2028)
  • Table 26. Europe Key Players Gene Editing Revenue (2022 & 2028) & (US$ Million)
  • Table 27. Europe Key Players Gene Editing Market Share (2022 & 2028)
  • Table 28. Europe Gene Editing Market Size by Type (2022-2028) (US$ Million)
  • Table 29. Europe Gene Editing Market Share by Type (2022-2028)
  • Table 30. Europe Gene Editing Market Size by Application (2022-2028) (US$ Million)
  • Table 31. Europe Gene Editing Market Share by Application (2022-2028)
  • Table 32. Asia-Pacific Key Players Gene Editing Revenue (2022 & 2028) & (US$ Million)
  • Table 33. Asia-Pacific Key Players Gene Editing Market Share (2022 & 2028)
  • Table 34. Asia-Pacific Gene Editing Market Size by Type (2022-2028) (US$ Million)
  • Table 35. Asia-Pacific Gene Editing Market Share by Type (2022-2028)
  • Table 36. Asia-Pacific Gene Editing Market Size by Application (2022-2028) (US$ Million)
  • Table 37. Asia-Pacific Gene Editing Market Share by Application (2022-2028)
  • Table 38. Key Players in Latin America
  • Table 39. Key Players in Middle East & Africa
  • Table 40. Thermo Fisher Scientific Company Details
  • Table 41. Thermo Fisher Scientific Description and Business Overview
  • Table 42. Thermo Fisher Scientific Gene Editing Product
  • Table 43. Thermo Fisher Scientific Revenue in Gene Editing Business 2022 & 2028
  • Table 44. Thermo Fisher Scientific Recent Development
  • Table 45. Merck Company Details
  • Table 46. Merck Description and Business Overview
  • Table 47. Merck Gene Editing Product
  • Table 48. Merck Revenue in Gene Editing Business 2022 & 2028
  • Table 49. Merck Recent Development
  • Table 50. Horizo​​n Discovery Company Details
  • Table 51. Horizo​​n Discovery Description and Business Overview
  • Table 52. Horizo​​n Discovery Gene Editing Product
  • Table 53. Horizo​​n Discovery Revenue in Gene Editing Business 2022 & 2028
  • Table 54. Horizo​​n Discovery Recent Development
  • Table 55. Sangamo BioSciences Company Details
  • Table 56. Sangamo BioSciences Description and Business Overview
  • Table 57. Sangamo BioSciences Gene Editing Product
  • Table 58. Sangamo BioSciences Revenue in Gene Editing Business 2022 & 2028
  • Table 59. Sangamo BioSciences Recent Development
  • Table 60. Integrated DNA Technologies Company Details
  • Table 61. Integrated DNA Technologies Description and Business Overview
  • Table 62. Integrated DNA Technologies Gene Editing Product
  • Table 63. Integrated DNA Technologies Revenue in Gene Editing Business 2022 & 2028
  • Table 64. Integrated DNA Technologies Recent Development
  • Table 65. Lonza Company Details
  • Table 66. Lonza Description and Business Overview
  • Table 67. Lonza Gene Editing Product
  • Table 68. Lonza Revenue in Gene Editing Business 2022 & 2028
  • Table 69. Lonza Recent Development
  • Table 70. New England Biolabs Company Details
  • Table 71. New England Biolabs Description and Business Overview
  • Table 72. New England Biolabs Gene Editing Product
  • Table 73. New England Biolabs Revenue in Gene Editing Business 2022 & 2028
  • Table 74. New England Biolabs Recent Development
  • Table 75. OriGene Technologies Company Details
  • Table 76. OriGene Technologies Description and Business Overview
  • Table 77. OriGene Technologies Gene Editing Product
  • Table 78. OriGene Technologies Revenue in Gene Editing Business 2022 & 2028
  • Table 79. OriGene Technologies Recent Development
  • Table 80. Transposagen Biopharmaceuticals Company Details
  • Table 81. Transposagen Biopharmaceuticals Description and Business Overview
  • Table 82. Transposagen Biopharmaceuticals Gene Editing Product
  • Table 83. Transposagen Biopharmaceuticals Revenue in Gene Editing Business 2022 & 2028
  • Table 84. Transposagen Biopharmaceuticals Recent Development
  • Table 85. Editas Medicine Company Details
  • Table 86. Editas Medicine Description and Business Overview
  • Table 87. Editas Medicine Gene Editing Product
  • Table 88. Editas Medicine Revenue in Gene Editing Business 2022 & 2028
  • Table 89. Editas Medicine Recent Development
  • Table 90. CRISPR Therapeutics Company Details
  • Table 91. CRISPR Therapeutics Description and Business Overview
  • Table 92. CRISPR Therapeutics Gene Editing Product
  • Table 93. CRISPR Therapeutics Revenue in Gene Editing Business 2022 & 2028
  • Table 94. CRISPR Therapeutics Recent Development
  • Table 95. RGen Solutions Company Details
  • Table 96. RGen Solutions Description and Business Overview
  • Table 97. RGen Solutions Gene Editing Product
  • Table 98. RGen Solutions Revenue in Gene Editing Business 2022 & 2028
  • Table 99. RGen Solutions Recent Development
  • Table 100. Sigma-Aldrich Company Details
  • Table 101. Sigma-Aldrich Description and Business Overview
  • Table 102. Sigma-Aldrich Gene Editing Product
  • Table 103. Sigma-Aldrich Revenue in Gene Editing Business 2022 & 2028
  • Table 104. Sigma-Aldrich Recent Development
  • Table 105. GeneCopoeia Company Details
  • Table 106. GeneCopoeia Description and Business Overview
  • Table 107. GeneCopoeia Gene Editing Product
  • Table 108. GeneCopoeia Revenue in Gene Editing Business 2022 & 2028
  • Table 109. GeneCopoeia Recent Development
  • Table 110. Genscript Biotech Company Details
  • Table 111. Genscript Biotech Description and Business Overview
  • Table 112. Genscript Biotech Gene Editing Product
  • Table 113. Genscript Biotech Revenue in Gene Editing Business 2022 & 2028
  • Table 114. Genscript Biotech Recent Development
  • Table 115. Gene Editing Market Trends
  • Table 116. Gene Editing Market Drivers
  • Table 117. Gene Editing Market Challenges
  • Table 118. Gene Editing Market Restraints
  • Table 119. Research Programs/Design for This Report
  • Table 120. Key Data Information from Secondary Sources
  • Table 121. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Gene Editing Market Share by Type in 2022 & 2028
  • Figure 2. Zinc finger nucleases (ZFNs) Features
  • Figure 3. Transcription Activator-Like Effector-based Nucleases (TALENs) Features
  • Figure 4. CRISPR-Cas system Features
  • Figure 5. Global Gene Editing Market Share by Application in 2022 & 2028
  • Figure 6. Biotechnology & Pharmaceutical Companies Case Studies
  • Figure 7. Academic & Government Research Institutes Case Studies
  • Figure 8. Contract Research Organizations Case Studies
  • Figure 9. Gene Editing Report Years Considered
  • Figure 10. Global Gene Editing Market Size and Growth Rate (2022-2028) (US$ Million)
  • Figure 11. Global Gene Editing Market Share by Regions (2022-2028)
  • Figure 12. Global Gene Editing Market Share by Players in 2021
  • Figure 13. Global Gene Editing Market Size Market Share by Type (2022-2028)
  • Figure 14. Global Gene Editing Market Size Market Share by Application (2022-2028)
  • Figure 15. Global Gene Editing Revenue Market Share by Application in 2021
  • Figure 16. North America Gene Editing Market Size 2022-2028 (US$ Million)
  • Figure 17. Europe Gene Editing Market Size 2022-2028 (US$ Million)
  • Figure 18. Asia-Pacific Gene Editing Market Size 2022-2028 (US$ Million)
  • Figure 19. Gene Editing Market Size in Latin America (2022-2028) (US$ Million)
  • Figure 20. Gene Editing Market Size in Middle East & Africa (2022-2028) (US$ Million)
  • Figure 21. Bottom-up and Top-down Approaches for This Report
  • Figure 22. Data Triangulation
  • Figure 23. Key Executives Interviewed
目次

Gemstones are elements of minerals which when polished and cut are used for making jewelry and other ornaments, as well as for decoration purposes.

Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication through direct correction of disturbances in normal physiology, engineering the immune response, and alteration of pathogen targets in the host is anticipated to drive the market with substantial opportunities.

According to our latest research, the global Gene Editing market size will reach USD 5441.3 million in 2028, growing at a CAGR of 7.9% over the analysis period.

Global Gene Editing Scope and Market Size

This report focuses on the global Gene Editing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Editing development in North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, etc.

Segment by Type

  • Zinc finger nucleases (ZFNs)
  • Transcription Activator-Like Effector-based Nucleases (TALENs)
  • CRISPR-Cas system

Segment by Application

  • Biotechnology & Pharmaceutical Companies
  • Academic & Government Research Institutes
  • Contract Research Organizations

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

By Company

  • Thermo Fisher Scientific
  • Merck
  • Horizo​​n Discovery
  • Sangamo BioSciences
  • Integrated DNA Technologies
  • Lonza
  • New England Biolabs
  • OriGene Technologies
  • Transposagen Biopharmaceuticals
  • Editas Medicine
  • CRISPR Therapeutics
  • RGen Solutions
  • Sigma-Aldrich
  • GeneCopoeia
  • Genscript Biotech

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Gene Editing Market Size Growth Rate by Type (2022-2028)
    • 1.2.2 Zinc finger nucleases (ZFNs)
    • 1.2.3 Transcription Activator-Like Effector-based Nucleases (TALENs)
    • 1.2.4 CRISPR-Cas system
  • 1.3 Market by Application
    • 1.3.1 Global Gene Editing Market Share by Application (2022-2028)
    • 1.3.2 Biotechnology & Pharmaceutical Companies
    • 1.3.3 Academic & Government Research Institutes
    • 1.3.4 Contract Research Organizations
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Gene Editing Market Size
  • 2.2 Gene Editing Market Size by Regions
    • 2.2.1 Gene Editing Growth Rate by Regions (2022-2028)
    • 2.2.2 Gene Editing Market Share by Regions (2022-2028)
  • 2.3 Industry Trends
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Use Cases

3 Key Players

  • 3.1 Gene Editing Revenue by Players (2022 & 2028)
  • 3.2 Gene Editing Key Players Headquarters and Area Served
  • 3.3 Key Players Gene Editing Product/Solution/Service
  • 3.4 Date of Enter into Gene Editing Market
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown by Type and by Application

  • 4.1 Global Gene Editing Market Size by Type (2022-2028)
  • 4.2 Global Gene Editing Market Size by Application (2022-2028)

5 North America

  • 5.1 North America Gene Editing Market Forecast (2022-2028)
  • 5.2 Gene Editing Key Players in North America
  • 5.3 North America Gene Editing Market Size by Type
  • 5.4 North America Gene Editing Market Size by Application

6 Europe

  • 6.1 Europe Gene Editing Market Forecast (2022-2028)
  • 6.2 Gene Editing Key Players in Europe
  • 6.3 Europe Gene Editing Market Size by Type
  • 6.4 Europe Gene Editing Market Size by Application

7 Asia-Pacific

  • 7.1 Asia-Pacific Gene Editing Market Forecast (2022-2028)
  • 7.2 Gene Editing Key Players in Asia-Pacific
  • 7.3 Asia-Pacific Gene Editing Market Size by Type
  • 7.4 Asia-Pacific Gene Editing Market Size by Application

8 Rest of World

  • 8.1 Latin America
    • 8.1.1 Latin America Gene Editing Market Analysis
    • 8.1.2 Key Players in Latin America
  • 8.2 Middle East & Africa
    • 8.2.1 Middle East & Africa Gene Editing Market Analysis
    • 8.2.2 Key Players in Middle East & Africa

9 International Player Profiles

  • 9.1 Thermo Fisher Scientific
    • 9.1.1 Thermo Fisher Scientific Company Details
    • 9.1.2 Thermo Fisher Scientific Description and Business Overview
    • 9.1.3 Thermo Fisher Scientific Gene Editing Introduction
    • 9.1.4 Thermo Fisher Scientific Revenue in Gene Editing Business (2022 & 2028)
    • 9.1.5 Thermo Fisher Scientific Recent Development
  • 9.2 Merck
    • 9.2.1 Merck Company Details
    • 9.2.2 Merck Description and Business Overview
    • 9.2.3 Merck Gene Editing Introduction
    • 9.2.4 Merck Revenue in Gene Editing Business (2022 & 2028)
    • 9.2.5 Merck Recent Development
  • 9.3 Horizo​​n Discovery
    • 9.3.1 Horizo​​n Discovery Company Details
    • 9.3.2 Horizo​​n Discovery Description and Business Overview
    • 9.3.3 Horizo​​n Discovery Gene Editing Introduction
    • 9.3.4 Horizo​​n Discovery Revenue in Gene Editing Business (2022 & 2028)
    • 9.3.5 Horizo​​n Discovery Recent Development
  • 9.4 Sangamo BioSciences
    • 9.4.1 Sangamo BioSciences Company Details
    • 9.4.2 Sangamo BioSciences Description and Business Overview
    • 9.4.3 Sangamo BioSciences Gene Editing Introduction
    • 9.4.4 Sangamo BioSciences Revenue in Gene Editing Business (2022 & 2028)
    • 9.4.5 Sangamo BioSciences Recent Development
  • 9.5 Integrated DNA Technologies
    • 9.5.1 Integrated DNA Technologies Company Details
    • 9.5.2 Integrated DNA Technologies Description and Business Overview
    • 9.5.3 Integrated DNA Technologies Gene Editing Introduction
    • 9.5.4 Integrated DNA Technologies Revenue in Gene Editing Business (2022 & 2028)
    • 9.5.5 Integrated DNA Technologies Recent Development
  • 9.6 Lonza
    • 9.6.1 Lonza Company Details
    • 9.6.2 Lonza Description and Business Overview
    • 9.6.3 Lonza Gene Editing Introduction
    • 9.6.4 Lonza Revenue in Gene Editing Business (2022 & 2028)
    • 9.6.5 Lonza Recent Development
  • 9.7 New England Biolabs
    • 9.7.1 New England Biolabs Company Details
    • 9.7.2 New England Biolabs Description and Business Overview
    • 9.7.3 New England Biolabs Gene Editing Introduction
    • 9.7.4 New England Biolabs Revenue in Gene Editing Business (2022 & 2028)
    • 9.7.5 New England Biolabs Recent Development
  • 9.8 OriGene Technologies
    • 9.8.1 OriGene Technologies Company Details
    • 9.8.2 OriGene Technologies Description and Business Overview
    • 9.8.3 OriGene Technologies Gene Editing Introduction
    • 9.8.4 OriGene Technologies Revenue in Gene Editing Business (2022 & 2028)
    • 9.8.5 OriGene Technologies Recent Development
  • 9.9 Transposagen Biopharmaceuticals
    • 9.9.1 Transposagen Biopharmaceuticals Company Details
    • 9.9.2 Transposagen Biopharmaceuticals Description and Business Overview
    • 9.9.3 Transposagen Biopharmaceuticals Gene Editing Introduction
    • 9.9.4 Transposagen Biopharmaceuticals Revenue in Gene Editing Business (2022 & 2028)
    • 9.9.5 Transposagen Biopharmaceuticals Recent Development
  • 9.10 Editas Medicine
    • 9.10.1 Editas Medicine Company Details
    • 9.10.2 Editas Medicine Description and Business Overview
    • 9.10.3 Editas Medicine Gene Editing Introduction
    • 9.10.4 Editas Medicine Revenue in Gene Editing Business (2022 & 2028)
    • 9.10.5 Editas Medicine Recent Development
  • 9.11 CRISPR Therapeutics
    • 9.11.1 CRISPR Therapeutics Company Details
    • 9.11.2 CRISPR Therapeutics Description and Business Overview
    • 9.11.3 CRISPR Therapeutics Gene Editing Introduction
    • 9.11.4 CRISPR Therapeutics Revenue in Gene Editing Business (2022 & 2028)
    • 9.11.5 CRISPR Therapeutics Recent Development
  • 9.12 RGen Solutions
    • 9.12.1 RGen Solutions Company Details
    • 9.12.2 RGen Solutions Description and Business Overview
    • 9.12.3 RGen Solutions Gene Editing Introduction
    • 9.12.4 RGen Solutions Revenue in Gene Editing Business (2022 & 2028)
    • 9.12.5 RGen Solutions Recent Development
  • 9.13 Sigma-Aldrich
    • 9.13.1 Sigma-Aldrich Company Details
    • 9.13.2 Sigma-Aldrich Description and Business Overview
    • 9.13.3 Sigma-Aldrich Gene Editing Introduction
    • 9.13.4 Sigma-Aldrich Revenue in Gene Editing Business (2022 & 2028)
    • 9.13.5 Sigma-Aldrich Recent Development
  • 9.14 GeneCopoeia
    • 9.14.1 GeneCopoeia Company Details
    • 9.14.2 GeneCopoeia Description and Business Overview
    • 9.14.3 GeneCopoeia Gene Editing Introduction
    • 9.14.4 GeneCopoeia Revenue in Gene Editing Business (2022 & 2028)
    • 9.14.5 GeneCopoeia Recent Development
  • 9.15 Genscript Biotech
    • 9.15.1 Genscript Biotech Company Details
    • 9.15.2 Genscript Biotech Description and Business Overview
    • 9.15.3 Genscript Biotech Gene Editing Introduction
    • 9.15.4 Genscript Biotech Revenue in Gene Editing Business (2022 & 2028)
    • 9.15.5 Genscript Biotech Recent Development

10 Market Dynamics

  • 10.1 Industry Trends
  • 10.2 Market Drives
  • 10.3 Market Challenges
  • 10.4 Market Restraints

11 Key Findings in This Report

12 Appendix

  • 12.1 Research Methodology
    • 12.1.1 Methodology/Research Approach
    • 12.1.2 Data Source
  • 12.2 Disclaimer
  • 12.3 Author Details